New Leaf Ventures III L.P. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 9:04 pm Purchase |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 5,643,788 11.000% |
5,018,941 (+803.23%) |
Filing |
| 2023-03-30 4:43 pm Purchase |
2023-03-23 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 624,847 15.400% |
299,431 (+92.01%) |
Filing |
| 2023-02-06 4:32 pm Purchase |
2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 325,416 9.800% |
4,231 (+1.32%) |
Filing |
| 2022-02-11 4:58 pm Purchase |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 321,186 9.800% |
28,553 (+9.76%) |
Filing |